年 〜
年

検索結果 8 件

Ex vivo hydrostatic pressure loading of atrial tissues activates profibrotic transcription via TGF-β signal pathway 63 2

Ex vivo hydrostatic pressure loading of atrial tissues activates profibrotic transcription via TGF-β signal pathway 63 2
デジタル博士論文障害者向け資料あり
張, 旭International Heart Journal Association2022-03-18International Heart Journal
国立国会図書館
  • 件名Mechanical stress Mechanotransduction Fibrogenesis Arrhythmia
  • 一般注記...nism of atrial fibrogenesis in response to mechanical str...

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis. 21 6

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis. 21 6
デジタル博士論文障害者向け資料あり
Ozutsumi, Takahiro, Namisaki, Tadashi, Shimozato, Naotaka, Kaji, Kosuke, Tsuji, Yuki, Kaya, Daisuke, Fujinaga, Yukihisa, Furukawa, Masanori, Nakanishi, Keisuke, Sato, Shinya, Sawada, Yasuhiko, Saikawa, Soichiro, Kitagawa, Koh, Takaya, Hiroaki, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-03-21International journal of molecular sciences
国立国会図書館
  • 件名non-alcoholic steatohepatitis hepatic fibrogenesis hepatocarcinogenesis canaglif...
  • 一般注記...nduced hepatic fibrogenesis and carcinogen......nhibited liver fibrogenesis by attenuating hepatic lipid ...

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis. 47 12

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis. 47 12
デジタル博士論文障害者向け資料あり
Okura, Yasushi, Namisaki, Tadashi, Moriya, Kei, Kitade, Mitsuteru, Takeda, Kosuke, Kaji, Kosuke, Noguchi, Ryuichi, Nishimura, Norihisa, Seki, Kenichiro, Kawaratani, Hideto, Takaya, Hiroaki, Sato, Shinya, Sawada, Yasuhiko, Shimozato, Naotaka, Furukawa, Masanori, Nakanishi, Keisuke, Saikawa, Soichiro, Kubo, Takuya, Asada, Kiyoshi, Yoshiji, HitoshiJohn Wiley & Sons, Inc.2016-12-28Hepatology research
国立国会図書館
  • 件名hepatic fibrogenesis hepatocarcinogenesis losartan...
  • 一般注記...eviate hepatic fibrogenesis and carcinogen......nduced hepatic fibrogenesis and carcinogenesis. The combi...

Deletion of Nardilysin Prevents the Development of Steatohepatitis and Liver Fibrotic Changes

Deletion of Nardilysin Prevents the Development of Steatohepatitis and Liver Fibrotic Changes
デジタル博士論文障害者向け資料あり
Ishizu, Shoko2015-01-23
インターネットで読める国立国会図書館全国の図書館
  • 件名...epatitis liver fibrogenesis ectodomain shedding tumor nec...

Ex vivo hydrostatic pressure loading of atrial tissues activates profibrotic transcription via TGF-β signal pathway

Ex vivo hydrostatic pressure loading of atrial tissues activates profibrotic transcription via TGF-β signal pathway
デジタル博士論文
張, 旭International Heart Journal Association2022-03-18International Heart Journal63 2p.367-374
インターネットで読める全国の図書館
  • 件名Mechanical stress Mechanotransduction Fibrogenesis Arrhythmia
  • 一般注記...nism of atrial fibrogenesis in response to mechanical str...

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
デジタル博士論文
Ozutsumi, Takahiro, Namisaki, Tadashi, Shimozato, Naotaka, Kaji, Kosuke, Tsuji, Yuki, Kaya, Daisuke, Fujinaga, Yukihisa, Furukawa, Masanori, Nakanishi, Keisuke, Sato, Shinya, Sawada, Yasuhiko, Saikawa, Soichiro, Kitagawa, Koh, Takaya, Hiroaki, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-03-21International journal of molecular sciences21 6p.Article No.2164-
インターネットで読める全国の図書館
  • 件名non-alcoholic steatohepatitis hepatic fibrogenesis hepatocarcinogenesis canaglif...
  • 一般注記...nduced hepatic fibrogenesis and carcinogen......nhibited liver fibrogenesis by attenuating hepatic lipid ...

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.
デジタル博士論文
Okura, Yasushi, Namisaki, Tadashi, Moriya, Kei, Kitade, Mitsuteru, Takeda, Kosuke, Kaji, Kosuke, Noguchi, Ryuichi, Nishimura, Norihisa, Seki, Kenichiro, Kawaratani, Hideto, Takaya, Hiroaki, Sato, Shinya, Sawada, Yasuhiko, Shimozato, Naotaka, Furukawa, Masanori, Nakanishi, Keisuke, Saikawa, Soichiro, Kubo, Takuya, Asada, Kiyoshi, Yoshiji, HitoshiJohn Wiley & Sons, Inc.2016-12-28Hepatology research47 12p.1317-1328
インターネットで読める全国の図書館
  • 件名hepatic fibrogenesis hepatocarcinogenesis losartan...
  • 一般注記...eviate hepatic fibrogenesis and carcinogen......nduced hepatic fibrogenesis and carcinogenesis. The combi...

G蛋白質共役型受容体を介した膵癌細胞の増殖・浸潤促進,抗アポトーシス機構の解明

G蛋白質共役型受容体を介した膵癌細胞の増殖・浸潤促進,抗アポトーシス機構の解明
デジタル文書・図像類
太田, 哲生, Ohta, Tetsuo金沢大学医薬保健研究域医学系2007-04平成18(2006)年度 科学研究費補助金 基盤研究(C) 研究成果報告書 = 2006 Fiscal Year Final Research Report2004-2006p.4p.-
全国の図書館
  • 件名...erived trypsin fibrogenesis
  • 一般注記...に作用して膵癌間質の線維増生(fibrogenesis)に深く関与していることが推察された。 Recently, ...

検索結果は以上です。